Skip to content
Innovative Tech
Diseases
Health Policy
HTA
Data Analysis
Clinical Practice
Contributors
BACK TO MAIN SITE
Impending Net Drug Price Transparency Regulatio...
By
Rene Pretorius
June 27, 2025
A new CMS rule to force drug price transparency is poised to reshape the pharmaceutical and healthcare landscape. With regulat...
Canada Launches Consultation for Essential Prescription Drugs List
ACIP Vaccine Policy Concerns
Efficacy of Ultomiris Pediatric TMA Treatment
KEYTRUDA Head Neck Cancer Approval: Transforming Treatment and Health Economics
Mavyret Acute Hepatitis C: Pioneering Treatment Expansion and Economic Implic...
Pfizer Conference Insights: Analyzing Bourla’s Strategic Vision Amid Po...
RFK Jr.’s ACIP Overhaul: Examining Vaccine Policy Implications
Elsa – FDA AI Tool: Navigating Efficiency and Ethics
The Case for Transparency in Peer Review: Enhancing Scientific Integrity and ...
BioNTech BMS Collaboration: Pioneering Advances in Solid Tumor Treatment with...
Pluvicto Prostate Cancer Trial: Phase III Results
Business Dynamics: How Novo Nordisk Lost GLP-1 Market Share
« Previous
1
…
3
4
5
6
7
…
11
Next »